Targeting cancer stem cells in refractory cancer (Regenerative Therapy, 2021, in press)

Targeting cancer stem cells in refractory cancer (Regenerative Therapy, 2021, in press)

In collaboration with Osaka University, Osaka International Cancer Institute, and Kyushu University, Dr. Miyoshi et al. updated that the innovative approaches for cancer stem cells, but also for immune cells and other mesenchymal cells. This novel approach in diagnosis and therapy will open an avenue to cancer precision medicine.